<DOC>
	<DOCNO>NCT00612963</DOCNO>
	<brief_summary>The purpose study evaluate efficacy Iocide oral rinse treatment Oral Candidiasis patient include limited patient receive radiation therapy previously receive radiation therapy head neck cancer , patient positive HIV/AIDS transplant patient .</brief_summary>
	<brief_title>Novel Rinse Treat Oral Candidiasis Cancer Patients</brief_title>
	<detailed_description>A four-week study design assessment clinical cure mycological eradication oral Candida isolate 40 cancer patient refer radiation oncologist course his/her treatment . An estimated 35 patient evaluable end study . Candida infection define positive clinical sign ( white plaque ) positive potassium hydroxide ( KOH ) preparation positive culture . Colonization define positive culture without sign clinical infection .</detailed_description>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis , Oral</mesh_term>
	<criteria>Males nonpregnant female currently receive post radiation therapy head neck cancer ; 18 year age ; With sign symptom oral candidiasis determine investigator ( ) ; Females use effective contraception method study . Patients must able willing comply study requirement , full understanding element , signature dating , inform consent prior initiation protocol specify procedure . Participating female subject must agree use adequate contraceptive measure trial . Before enter study , woman childbearing age test pregnancy urine pregnancy test . History , current evidence , significant acute chronic medical psychiatric condition would render examination difficult invalid prevent subject active study participation ; Inability use oral rinse ; Use concomitant medication , opinion Study Director , might interfere outcome study ( e.g . anabolic steroid excessive corticosteroid , large dos aspirin ( one 325 mg tablet per day ) , phenytoin , lithium , coumadin Iodine contain preparation [ use iodize table salt acceptable ] ) . Steroids , therapeutic dos nonsteroidal antiinflammatory agent , estrogen therapy agent oral contraceptive OK use long baseline dose remain steady end study ; Use antifungal medication last 30 day , purported sensitivity allergy iodine ; Pregnant nursing patient effect Iocide fetus infant establish ; History thyroid disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Candidiasis , Oral</keyword>
	<keyword>Thrush</keyword>
	<keyword>Candidiasis</keyword>
</DOC>